Back to BCRX
STATE STREET CORP BCRX Position History
BioCryst Pharmaceuticals, Inc. • Healthcare
Quarters held
12
Latest value
$151.9M
Q2 2026
Peak value
$151.9M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $76.5M |
| Q1 2024 | $88.8M |
| Q2 2024 | $57.8M |
| Q3 2024 | $67.3M |
| Q4 2024 | $56.4M |
| Q1 2025 | $58.6M |
| Q2 2025 | $76.2M |
| Q3 2025 | $74.4M |
| Q4 2025 | $86.4M |
| Q1 2026 | $116.2M |
| Q2 2026 | $151.9M |
| Q2 2026 | $151.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $151.9M | 15.19M | — | — |
| Q2 2026 | $151.9M | 15.19M | — | — |
| Q1 2026 | $116.2M | 12.21M | — | — |
| Q4 2025 | $86.4M | 11.07M | — | — |
| Q3 2025 | $74.4M | 9.81M | — | — |
| Q2 2025 | $76.2M | 8.51M | — | — |
| Q1 2025 | $58.6M | 7.81M | — | — |
| Q4 2024 | $56.4M | 7.50M | — | — |
| Q3 2024 | $67.3M | 8.85M | — | — |
| Q2 2024 | $57.8M | 9.35M | — | — |
| Q1 2024 | $88.8M | 17.48M | — | — |
| Q4 2023 | $76.5M | 12.78M | — | — |
Other funds holding BCRX
$179.6M
$160.1M
$158.9M
$152.7M
$57.5M